Doxecitine and doxribtimine
- Part D specialty tier in 95% of formularies (2026Q3)
- KYGEVVI
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Doxecitine and doxribtimine: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store reconstituted KYGEVVI solution at controlled room temperature or in the refrigerator.
- Freezing
- Not addressed
- Room temperature
- at or below 30°C (86°F)
Label statement
Store KYGEVVI packets at 20°C to 25°C (68°F to 77°F); excursion permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
- Room temperature
- at or below 25°C (77°F)
Label statement
Store KYGEVVI packets at room temperature between 68°F to 77°F (20°C to 25°C).
- Room temperature
- at or below 25°C (77°F)
Label statement
Store prepared KYGEVVI solution at room temperature between 68°F to 77°F (20°C to 25°C) or in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (6)
- Store KYGEVVI packets at 20°C to 25°C (68°F to 77°F); excursion permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
- Store reconstituted KYGEVVI solution at controlled room temperature or in the refrigerator.
- Discard KYGEVVI solution 16 hours after reconstitution or after taking or giving the 3 doses, whichever comes first [see Dosage and Administration (2.5) ].
- Store KYGEVVI packets at room temperature between 68°F to 77°F (20°C to 25°C).
- Store prepared KYGEVVI solution at room temperature between 68°F to 77°F (20°C to 25°C) or in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Throw away (discard) any remaining solution 16 hours after preparing or after taking or giving the 3 doses, whichever comes first.
FDA label version 3, effective November 10, 2025. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.